Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M. Navasa, F. Casafont, G. Clemente, C. Guarner, M. de la Mata, R. Planas, et al.
Consenso sobre peritonitis bacteriana espontánea en la cirrosis hepática: diagnóstico, tratamiento y profilaxis.
Gastroenterol Hepatol, 24 (2001), pp. 37-46
[2.]
A. Rimola, G. García-Tsao, M. Navasa, L.J.V. Piddock, R. Planas, B. Bernard, et al.
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document.
J Hepatol, 32 (2000), pp. 142-153
[3.]
D. Larrey, T. Vial, A. Micaleff, G. Babary, M. Moricheau-Brauchant, H. Michel, et al.
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
Gut, 33 (1992), pp. 368-371
[4.]
Medicine Control Agency.
Cholestatic jaundice with co-amoxiclav.
Curr Probl Pharmacov, 19 (1993), pp. 2
[5.]
L.A. García-Rodríguez, B.H. Stricker, H.J. Zimmerman.
Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.
Arch Intern Med, 156 (1996), pp. 1327-1332
[6.]
D.K. George, D.H.G. Crawford.
Antibacterial-induced hepatotoxicity.
Drug Saf, 15 (1996), pp. 79-85
[7.]
R.J. Andrade, M.I. Lucena, H. Sánchez-Martínez, J.M. Pérez-Serrano, A. Gómez-Outes.
Norfloxacin induced cholestatic jaundice.
Am J Gastroenterol, 93 (1998), pp. 2309-2311
[8.]
M.I. Lucena, R. Camargo, R.J. Andrade, C.J. Pérez-Sánchez, F. Sánchez de la Cuesta.
Comparison of two clinical scales for causality assessment in hepatotoxicity.
Hepatology, 33 (2001), pp. 123-130
[9.]
R.J. Andrade, M.I. Lucena, M.C. Fernández-Sánchez, J.L. Vega, R. Camargo.
Hepatotoxicty in patients with cirrhosis, an often unrecognized problem. Lessons from a fatal case related with amoxicillin/clavulanic acid.
Dig Dis Sci, (2001),
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
